AINOS INC (AIMD) Stock Price & Overview

NASDAQ:AIMDUS00902F4028

Current stock price

1.47 USD
+0.02 (+1.38%)
At close:
1.4999 USD
+0.03 (+2.03%)
After Hours:

The current stock price of AIMD is 1.47 USD. Today AIMD is up by 1.38%. In the past month the price increased by 9.7%. In the past year, price decreased by -44.53%.

AIMD Key Statistics

52-Week Range1.26 - 4.4999
Current AIMD stock price positioned within its 52-week range.
1-Month Range1.3201 - 1.79
Current AIMD stock price positioned within its 1-month range.
Market Cap
10.261M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-4.29
Dividend Yield
N/A

AIMD Stock Performance

Today
+1.38%
1 Week
+4.26%
1 Month
+9.70%
3 Months
-30.33%
Longer-term
6 Months -60.90%
1 Year -44.53%
2 Years -74.21%
3 Years -93.24%
5 Years N/A
10 Years N/A

AIMD Stock Chart

AINOS INC / AIMD Daily stock chart

AIMD Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to AIMD. When comparing the yearly performance of all stocks, AIMD is a bad performer in the overall market: 91% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

AIMD Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to AIMD. Both the profitability and financial health of AIMD have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AIMD Earnings

Next Earnings DateMay 11, 2026
Last Earnings DateMar 5, 2026
PeriodQ3 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

AIMD Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

AIMD Groups

Sector & Classification

AIMD Financial Highlights

Over the last trailing twelve months AIMD reported a non-GAAP Earnings per Share(EPS) of -4.29. The EPS increased by 68.99% compared to the year before.


Income Statements
Revenue(TTM)113.10K
Net Income(TTM)-14.96M
Industry RankSector Rank
PM (TTM) N/A
ROA -65.95%
ROE -148.9%
Debt/Equity 1.1
Chartmill High Growth Momentum
EPS Q2Q%60.51%
Sales Q2Q%N/A
EPS 1Y (TTM)68.99%
Revenue 1Y (TTM)178.57%

AIMD Ownership

Ownership
Inst Owners3.68%
Shares6.98M
Float2.72M
Ins Owners22.67%
Short Float %3.07%
Short Ratio0.11

About AIMD

Company Profile

AIMD logo image Ainos, Inc. is a diversified medtech company, which engages in the development of medical technologies for point-of-care testing and safe and novel medical treatment for a broad range of disease indications. The company is headquartered in Houston, Texas and currently employs 44 full-time employees. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. The company is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.

Company Info

IPO: 1996-08-08

AINOS INC

3050 Post Oak Blvd,, Suite 510-T80

Houston TEXAS US

Employees: 44

AIMD Company Website

AIMD Investor Relations

Phone: 12818986586

AINOS INC / AIMD FAQ

Can you describe the business of AINOS INC?

Ainos, Inc. is a diversified medtech company, which engages in the development of medical technologies for point-of-care testing and safe and novel medical treatment for a broad range of disease indications. The company is headquartered in Houston, Texas and currently employs 44 full-time employees. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. The company is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.


What is the current price of AIMD stock?

The current stock price of AIMD is 1.47 USD. The price increased by 1.38% in the last trading session.


Does AINOS INC pay dividends?

AIMD does not pay a dividend.


What is the ChartMill rating of AINOS INC stock?

AIMD has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


What sector and industry does AINOS INC belong to?

AINOS INC (AIMD) operates in the Information Technology sector and the Technology Hardware, Storage & Peripherals industry.


Can you provide the PE ratio for AIMD stock?

AINOS INC (AIMD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.29).


Can you provide the upcoming earnings date for AINOS INC?

AINOS INC (AIMD) will report earnings on 2026-05-11.